Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Revenue

Catalyst Pharmaceuticals had revenue of $146.56M in the quarter ending June 30, 2025, with 19.44% growth. This brings the company's revenue in the last twelve months to $558.50M, up 28.55% year-over-year. In the year 2024, Catalyst Pharmaceuticals had annual revenue of $491.73M with 23.49% growth.

• Revenue (ttm): $558.50M
• Revenue Growth: +28.55%
• P/S Ratio: 4.36
• Revenue / Employee: $3,085,630
• Employees: 181
• Market Cap: 2.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	491.73M	93.53M	23.49%
Dec 31, 2023	398.20M	184.00M	85.90%
Dec 31, 2022	214.20M	73.37M	52.10%
Dec 31, 2021	140.83M	21.76M	18.27%
Dec 31, 2020	119.07M	16.77M	16.39%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.